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Valvular heart diseases often require intervention. In indus-
trialized countries, the reduced incidence of rheumatic valve
disease and the prolonged life expectancy account for a
progressive increase in the incidence of degenerative valve
disease. Their management remains difficult, despite the
production of guidelines prepared by organizations (1,2).
Because randomized clinical trials are particularly scarce in
this setting, most recommendations are supported by only a
Level of Evidence: C (consensus of opinion of experts
established from small and retrospective studies). This can
explain in part an inconsistent compliance with guidelines.
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In particular, the management of severe organic mitral
regurgitation (MR) is controversial and the optimal timing
of surgical intervention remains unclear. Mitral valve sur-
gery is indicated in symptomatic patients with severe pri-
mary MR (class I) to prevent left ventricular (LV) dysfunc-
tion and improve outcome. In asymptomatic patients,
indications for surgery should integrate the severity of MR,
the probability of a durable valve repair and the conse-
quences of MR on cardiac geometry and function, such as
LV dilation, systolic dysfunction, atrial fibrillation, and/or
pulmonary arterial hypertension. Indeed, surgery is recom-
mended in the presence of LV impairment, defined as a LV
ejection fraction!60% and/or a left ventricular end-systolic
diameter (LVESD) "40 mm (in American College of
Cardiology/American Heart Association guidelines) or!45
mm (in European Society of Cardiology guidelines). Severe,
prolonged MR results in LV remodeling and initially
normal forward stroke volume. The LV ejection fraction
represents the sum of the forward LV ejection fraction and
the regurgitant fraction. The evaluation of LV ejection
fraction, thus, often leads in apparent preservation of LV
function and may result in incorrect estimation of the real
impact of MR on the ventricle. The use of LVESD could
thus appear more appropriate, even if data on its prognostic
importance and its association with postoperative outcome
are limited, and despite guidelines’ differences in the thresh-
old that should be used ("40 mm vs. !45 mm).
In this regard, the paper by Tribouilloy et al. (3) in this issue
of the Journal provides an important contribution. A total of
861 patients with MR due to flail leaflets were enrolled
between 1980 and 2004 in the MIDA (Mitral Regurgitation
International Database) registry, a multicenter registry involv-
ing 4 European centers and 1 center in the U.S. Follow-up
collection was completed in each center in !95% of their
cohort. Only patients in whom LVESD was measured were
included in the analysis. Among 739 patients, 74% had a
LVESD"40 mm and 25% were managed only conservatively
with a mean follow-up of 2.2 # 3.1 years. In addition, the
management of 75% of the whole cohort was medical followed
by surgery and mean follow-up was 6.1 # 3.7 years. Under
conservative management, LVESD "40 mm was associated
with approximately a 2- and 3-fold increase in overall and
cardiac mortality risks, respectively. Interestingly, LVESD was
also an independent determinant of lower survival even after
surgical correction of MR. After adjusting for variables used as
indication for surgery in guidelines (i.e., symptoms, ejection
fraction, and atrial fibrillation), LVESD remained indepen-
dently associated with poor outcome. When surgery was
analyzed as a time-dependent variable in the multivariate
model, the results showed that mitral valve surgery subse-
quently reduced the risk of mortality. The correction of
LVESD to body surface area was used to avoid a misclassifi-
cation of patients with large stature. Similar results were found
using a cut-off of "22 mm/m2.
The prognosis of patients with mitral flail leaflets was
previously studied by Ling et al. (4). They already observed that
MR due to flail leaflet, when treated conservatively, is associ-
ated with excess morbidity and mortality and that surgery
allows an improvement of prognosis. Nonetheless, this “pro-
phylactic and aggressive strategy” is based on the premise that
the valve will be repairable (78% of the patients submitted to
surgery in the present study), which is not always the case. The
rate of mitral valve repair varies largely from institution to
institution and from surgeon to surgeon. In the hands of
experienced surgeons, !90% of the valves of patients with
severe MR are repaired. However, the proportion was only
41% in a European Heart survey (5). By contrast, Rosenhek
et al. (6) reported the results of a series of 56 patients with
severe MR due to flail leaflets who underwent serial clinical
and echocardiographic examinations and were only referred to
surgery when a class I or IIa indication, according to the
guidelines, was reached. This study revealed that asymptomatic
patients with severe organic MR due to flail leaflet had similar
survival rates compared with the general population and may
be safely followed up using a “watchful waiting” strategy.
However, the patients included in the study of Rosenhek et al.
(6) were younger and had lower LV size, which suggests that
these patients were probably less sick than those included by
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Ling et al. (4). The results reported by Tribouilloy et al. (3), as
well as those previously published by Grigioni et al. (7),
confirm that severe MR due to flail leaflet is not a benign
condition. The impact of LVESD on survival was not signif-
icantly affected by the origin of patients (Europe vs. U.S.;
p $ 0.14), suggesting that these results may be clinically
applicable worldwide. Although the present study provides
useful clinical information, only flail leaflets were included. The
application of these results to other forms of severe organicMR
should not be done automatically. Hence, organic MR tends
to progress over time but the progression is variable.
Higher rates of progression are mainly determined by the
development of a new flail leaflet (8). In addition, sudden
death is relatively common in patients with flail leaflet
who are treated medically (9).
The echocardiographic measurement of LVESD should
systematically be obtained. Although it seems relatively easy,
some pitfalls exist. The ultrasonic beam should be directed
between the mitral valve echoes and the papillary muscles
echoes. Small differences in this direction can result in different
measurements in the presence of a spherical LV dilation due to
MR. It is recommended to use as end-systole peak downward
motion of the septum (10), which usually occurs slightly before
the peak upward motion of the posterior endocardium, but the
difference can be greater in the presence of LV dyssynchrony.
Importantly, the cursor should be perpendicular to the septum
and the posterior wall. An oblique orientation would overes-
timate LV diameter, sometimes largely. In this case, it is
preferable to use anatomic M-mode despite its much lower
temporal resolution than conventional M-mode or to obtain
the measurement from a stop-frame 2-dimensional echocar-
diogram despite the difficulty to precisely select the end-systolic
frame. Therefore, when LVESD becomes close to the cut-off
value of 40 mm, it is preferable to repeat the echocardiographic
examination after a short period of time rather than taking an
important decision based on this single parameter.
It is also necessary, when the patient is asymptomatic, to
ensure that MR is really severe. In the study of Tribouilloy
et al. (3), a flail leaflet was considered as a surrogate of severe
MR, although any amount of flail does not necessarily imply
severe MR. At the beginning of the registry, quantitative
methods for grading MR were not yet developed. Since that
time, it has been demonstrated that quantifyingMR according
to current guidelines provides powerful prediction of the
clinical outcome of asymptomatic MR (11).
New echocardiographic tools could also enhance the
management of patients with severe organic MR. Real-time
3-dimensional echocardiography allows accurate assessment
of LV geometry and provides reproducible measurements of
LV end-systolic and -diastolic volumes. The LV function
could also be better estimated with new indices using tissue
Doppler imaging and 2-dimensional speckle-tracking im-
aging. Measurements of longitudinal myocardial deforma-
tion improve the detection of subclinical LV dysfunction
and were recently reported as an accurate predictor of
postoperative LV dysfunction (12). The LV contractile
reserve, assessed with exercise echocardiography could also
play a role in the assessment of patients with valvular heart
disease and this method should be investigated in the setting
of severe organic MR. However, these new tools need to be
evaluated in large multicenter registries with long-term
follow-up. Meanwhile, the noteworthy study by Tribouilloy
et al. (3) convincingly emphasizes that patients with severe
primary MR, at least as a consequence of flail leaflets, who
have LVESD"40 mm or" 22 mm/m2 should be promptly
referred for surgical intervention.
Reprint requests and correspondence: Prof. Luc A. Pierard, Head
of Department of Cardiology, University Hospital, CHU Sart Til-
man, B-4000 Liege, Belgium. E-mail: lpierard@chu.ulg.ac.be.
REFERENCES
1. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines
for the management of patients with valvular heart disease: a report of
the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (Writing Committee to Revise the
1998 Guidelines for the Management of Patients With Valvular Heart
Disease). J Am Coll Cardiol 2006;48:e1–148.
2. Vahanian A, Baumgartner H, Bax J, et al., on behalf of Task Force on
the Management of Valvular Hearth Disease of the European Society
of Cardiology; ESC Committee for Practice Guidelines. Guidelines
on the management of valvular heart disease: the Task Force on the
Management of Valvular Heart Disease of the European Society of
Cardiology. Eur Heart J 2007;28:230–68.
3. Tribouilloy C, Grigioni F, Avierinos JF, et al., on behalf of the MIDA
Investigators. Survival implication of left ventricular end-systolic
diameter in mitral regurgitation due to flail leaflets: a long-term
follow-up multicenter study. J Am Coll Cardiol 2009;54:1961–8.
4. Ling H, Enriquez-Sarano M, Seward J, et al. Clinical outcome of
mitral regurgitation due to flail leaflets. N Engl J Med 1996;335:
1417–23.
5. Mirabel M, Iung B, Baron G, et al. What are the characteristics of
patients with severe, symptomatic, mitral regurgitation who are denied
surgery? Eur Heart J 2007;28:1358–65.
6. Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waiting
in asymptomatic severe mitral regurgitation. Circulation 2006;113:
2238–44.
7. Grigioni F, Tribouilloy C, Avierinos JF, et al. Outcomes in mitral
regurgitation due to flail leaflets: a multicenter European study. J Am
Coll Cardiol Img 2008;1:133–41.
8. Enriquez-Sarano M, Basmadjian A, Rossi A, Bailey K, Seward J,
Tajik A. Progression of mitral regurgitation: a prospective Doppler
echocardiographic study. J Am Coll Cardiol 1999;34:1137–44.
9. Grigioni F, Enriquez-Sarano M, Ling L, et al. Sudden death in mitral
regurgitation due to flail leaflet. J Am Coll Cardiol 1999;34:2078–85.
10. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations
regarding quantitation in M-mode echocardiography: results of a
survey of echocardiographic measurements. Circulation 1978;58:
1072–83.
11. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quan-
titative determinants of the outcome of asymptomatic mitral regurgi-
tation. N Engl J Med 2005;352:875–83.
12. Lancellotti P, Cosyns B, Zacharakis D, et al. Importance of left
ventricular longitudinal function and functional reserve in patients
with degenerative mitral regurgitation: assessment by two-dimensional
speckle tracking. J Am Soc Echocardiogr 2008;21:1331–6.
Key Words: dimensions y echocardiography y left ventricle y mitral
valve y prognosis.
1970 Pierard and Magne JACC Vol. 54, No. 21, 2009
A New Look to an Old Measurement November 17, 2009:1969–70
